Explore
Validate
Learn
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA1-37710 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- VEGF Receptor 1 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- This antibody is predicted to react with mouse and rat based on sequence homology.
Submitted references A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas.
Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas.
Agulnik M, Costa RLB, Milhem M, Rademaker AW, Prunder BC, Daniels D, Rhodes BT, Humphreys C, Abbinanti S, Nye L, Cehic R, Polish A, Vintilescu C, McFarland T, Skubitz K, Robinson S, Okuno S, Van Tine BA
Annals of oncology : official journal of the European Society for Medical Oncology 2017 Jan 1;28(1):121-127
Annals of oncology : official journal of the European Society for Medical Oncology 2017 Jan 1;28(1):121-127
Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas.
Okamoto S, Nitta M, Maruyama T, Sawada T, Komori T, Okada Y, Muragaki Y
Brain tumor pathology 2016 Apr;33(2):129-36
Brain tumor pathology 2016 Apr;33(2):129-36
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of FLT-1/VEGFR1 using anti-FLT-1/VEGFR1 Polyclonal Antibody (Product # PA5-32408) in Placenta Tissue. The recommened dilution for this antibody in immunohistochemistry applications is 1:50.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of VEGF Receptor 1 using a polyclonal antibody (Product # PA1-37710).
